(ee FLOOR nih theen) Brand: Vaniqa
• Eflornithine topical is for outside use only.
• Continue to use eflornithine topical even if you do not see immediate results. Abbreviation in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment with eflornithine topical must be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment with eflornithine topical.
• Eflornithine interferes with a chemical in the hair follicles of the skin. This results in slower hair growth where eflornithine topical is applied.
• Eflornithine topical is used to reduce unwanted facial hair in women. Eflornithine topical does not permanently remove hair or "cure" unwanted facial hair. Eflornithine topical will help you manage your condition and improve your appearance.
• Eflornithine topical may also be used for purposes another than those listed in this medicine guide.
• Do not use eflornithine topical if you have had an allergic reaction to it in the past.
• Eflornithine topical is in the FDA pregnancy category C. This means that it is not known whether eflornithine topical will harm an unborn child. Do not use this medicine without first talking to your doctor if you are pregnant.
• It is also not known whether eflornithine passes into breast milk. Do not use eflornithine topical without first talking to your doctor if you are breast-feeding a baby.
• Eflornithine topical has not been authorized for use by children younger than 12 years of age.
• Apply eflornithine topical exactly as directed by your doctor. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.
• Eflornithine topical does not permanently remove hair or "cure" unwanted facial hair. It is not a hair remover (depilatory). You will need to continue using your current hair removal techniques. Eflornithine topical will help you manage your condition and improve your appearance.
• Eflornithine topical is for outside use only.
• Eflornithine topical is generally applied twice daily, at least eight hours separately, or as directed by your doctor.
• Wash your hands till and after every application of eflornithine topical.
• Remove any facial hair that is gift using your current hair removal techniques. Wait at least 5 minutes after hair removal till applying eflornithine topical. Apply a thin layer of eflornithine topical to the affected areas of the person and nearby affected areas under the chin and rub it in thoroughly.
• Cosmetics or sunscreen may be used after applying eflornithine topical, but you must wait a little minutes to let the treatment to be absorbed till applying them.
• Do not wash the treatment areas for at least 4 hours after application of eflornithine topical.
• Avoid getting this medicine in your eyes, nose, or mouth. If this occurs, wash the area with water. If eflornithine topical gets in your eyes, rinse them thoroughly with water and contact your doctor.
• Eflornithine topical may reason temporary redness, rash, burning, stinging, or tingling, especially if it is applied to broken or irritated skin. If irritation develops, reduce the application of eflornithine topical to once a day. If irritation continues, stop using eflornithine topical and contact your doctor.
• Continue to use eflornithine topical even if you do not see immediate results. Abbreviation in facial hair occurs gradually. Improvement may be seen as early as 4 to 8 weeks of treatment, however it may take longer in some individuals. If no improvement is seen after 6 months of use, treatment with eflornithine topical must be discontinued. Hair growth may return to pretreatment levels approximately 8 weeks after discontinuation of treatment with eflornithine topical.
• Store eflornithine topical at room temperature away from moisture and heat. Do not let the medicine to freeze.
• If you miss a doze of eflornithine topical, skip the doze you missed and apply your following regularly scheduled doze as directed. Do not apply a double doze of this medicine or try to "make up" a missed dose.
• An overdose of eflornithine topical is not likely to occur. If the cream has been ingested, or if you suspect an overdose has occurred, contact your doctor, hospital abnormal room, or poison control center for advice.
• Avoid getting this medicine in your eyes, nose, or mouth. If this occurs, wash the area with water. If eflornithine topical gets in your eyes, rinse thoroughly with water and contact your doctor.
• Eflornithine topical may reason temporary redness, rash, burning, stinging, or tingling, especially if it is applied to broken or irritated skin. If irritation develops, reduce the application of eflornithine topical to once a day. If irritation continues, stop using eflornithine topical and contact your doctor.
• Hair bumps (folliculitis) may also occur. If these continue, contact your doctor.
• Side effects another than those listed here may also occur. Conversation to your doctor about any side effect that seems unusual or that is especially bothersome. You may message side effects to FDA at 1-800-FDA-1088.
• Till using eflornithine topical, conversation to your doctor if you are taking any another prescription or over-the-counter medications, especially if you are using any another topical preparations. You may not be able to use eflornithine topical, or you may require a dosage adjustment or particular monitoring during treatment.
• Drugs another than those listed here may also interact with eflornithine topical. Conversation to your doctor and pharmacist till taking or using any another prescription or over-the-counter medicines.
• Your pharmacist has additional information about eflornithine topical written for health professionals that you may read.
Remember, hold this and all another medicines out of the reach of children, never share your medicines with others, and use this medicine only for the indication prescribed.
Disclaim: Each effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses external of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way must be construed to indicate that the drug or drug combination is safety, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the help of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.